Media Contact
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday:
- Andrea Greif
Vice President, Communications
(914) 821-8958
andrea.greif@lls.org
Short-Term Health Plans Leave Patients Vulnerable to Major Medical Bills, According to New Research
View full news release here. Washington, D.C. (February 25, 2020) – The Leukemia & Lymphoma Society (LLS) released today new research which shows the significant financial costs facing consumers treated for five serious conditions while enrolled in short-term health plans: lymphoma, heart attack, lung cancer, diabetes and mental health hospitalizations. The study, conducted by actuarial fir...
24 Patient Groups Endorse Expedited Supreme Court Review of ACA Case
WASHINGTON, D.C. (January 3, 2020) — Twenty-four organizations representing millions of patients strongly support the petitions filed today by state attorneys general and by the U.S. House of Representatives that seek expedited U.S. Supreme Court review of last month’s Texas v. United States ruling. The coalition issued the following statement: “Our organizations, representing millions of individuals and ...
Burlington Stores Raises More Than $5.8 Million For LLS This Year
Rye Brook, NY, (January 7, 2020) – Burlington Stores and The Leukemia & Lymphoma Society (LLS) teamed up for the 18th consecutive year to raise critical funds for cancer research and patient support to help save lives and bring smiles to those impacted. From September 9 through December 2, customers at Burlington’s more than 700 locations nationwide were encouraged to donate $1 or more at checkout to support ...
28 Patient Groups Disappointed in 5th Circuit Court Ruling in Texas v. U.S.
Washington, D.C., (December 19, 2019) — Yesterday, the U.S. Court of Appeals for the Fifth Circuit issued their ruling in Texas v. United States, striking down the Affordable Care Act’s individual mandate and remanding back to the district court the decision as to whether key patient protections will remain in the future. In response, more than 25 patient groups issued the following statement: “It is importa...
LLS and ASH Team Up to Connect Cancer Patients to Clinical Trials
Collaboration will provide critical clinical trial navigation services and support to patients and families Rye Brook, NY, (December 6, 2019) - The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS’s unique free service providing clinical trials navigation and support to blood cancer patients and their families. With o...
Walgreens, Susan G. Komen and LLS Collaborate to Support Research
Deerfield, Ill., Dallas and Rye Brook, N.Y., (Oct. 22, 2019) — Walgreens announced today a new collaboration with Susan G. Komen and The Leukemia & Lymphoma Society to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, over the next five years. Through a combination of corporate donations and in-sto...
Nearly 60% of Blood Cancer Patients Covered By Medicare Delay or Forgo Treatment
View full multimedia release here. Rye Brook, N.Y. (October 21, 2019) – Survival of older patients with blood cancers continues to improve as more effective, less toxic therapies are introduced. However, these lifesaving treatments often are expensive and many cancer patients face financial burdens caused by ever-increasing healthcare costs. In fact, according to a new study released toda...
WWE® AND LLS JOIN FORCES TO HELP CANCER PATIENTS AND FAMILIES
Stamford, Conn. and Rye Brook, N.Y. (October 03, 2019) – WWE and WWE Superstar Roman Reigns are teaming up with The Leukemia & Lymphoma Society (LLS) in the fight against cancer. For Reigns, the cause is personal – he is in remission for the second time from chronic myeloid leukemia (CML). The new partnership with LLS, the world’s largest nonprofit fighting blood cancers, will propel the organization’...